European Journal of Surgical Oncology
Volume 35, Issue 1 , Pages 3-10 , January 2009

The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors)

  • D.J. Lips

      Affiliations

    • Department of Surgery, Jeroen Bosch Hospital, P.O. Box 90153, 5200 ME Den Bosch, the Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 62 486 1898.
    • ,
  • N. Barker

      Affiliations

    • Hubrecht Institute for Developmental Biology and Stem Cell Research, Netherlands Institute of Developmental Biology, Royal Netherlands Academy of Sciences, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands
    • ,
  • H. Clevers

      Affiliations

    • Hubrecht Institute for Developmental Biology and Stem Cell Research, Netherlands Institute of Developmental Biology, Royal Netherlands Academy of Sciences, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands
    • ,
  • A. Hennipman

      Affiliations

    • Department of Surgery, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands

,Accepted 9 July 2008.

References 

  1. Pikaar A, Nortier JWR, Griffioen G, Vasen HFA. Desmoid tumoren bij patienten met familiaire adenomateuze polyposis. NTvG. 2002;146(29):1355–1359
  2. Nuyttens JJ, Rust PF, Thomas CR. Turrisi AT III. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumor. Cancer. 2000;88:1517–1523
  3. Pignatti G, Barbanti-Brodano G, Ferrari D, et al. Extraabdominal desmoid tumor. Clin Orthop Res. 2000;375:207–213
  4. Godwin Y, McCulloch TA, Sully L. Extra-abdominal desmoid tumour of the breast: review of the primary management and the implications for breast reconstruction. Br J Plast Surg. 2001;54(3):268–271
  5. Eccles DM, van der Luijt R, Breukel C, et al. Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet. 1996;59(6):1193–1201
  6. Scott RJ, Froggatt NJ, Trembath RC, Evans DG, Hodgson SV, Maher ER. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation. Hum Mol Genet. 1996;5(12):1921–1924
  7. Bandipalliam P, Balmana J, Syngal S. Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors. Surgery. 2004;135(6):683–689
  8. Benoit L, Faivre L, Cheynel N, et al. 3′ Mutation of the APC gene and family history of FAP in a patient with apparently sporadic desmoid tumors. J Clin Gastroenterol. 2007;41(3):297–300
  9. Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol. 2006;21(7):1390–1397
  10. Merchant NB, Lewis JJ, Woodruff JM, Leung DHY, Brennan MF. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer. 1999;86:2045–2052
  11. Lev D, Kotilingam D, Wei C, et al. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007;25(13):1785–1791
  12. Heinrich MC, McArthur GA, Demetri GD, et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol. 2006;24(7):1195–1203
  13. Azzarelli A, Gronchi A, Bertulli R, et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer. 2001;92(5):1259–1264
  14. Nieuwenhuis MH, De Vos Tot Nederveen C, Botma A, et al. Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008;6(2):215–219
  15. Ishizuka M, Hatori M, Dohi O, et al. Expression profiles of sex steroid receptors in desmoid tumors. Tohoku J Exp Med. 2006;210(3):189–198
  16. Deyrup AT, Tretiakova M, Montag AG. Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases. Cancer. 2006;106(1):208–213
  17. Li M, Cordon-Cardo C, Gerald WL, Rosai J. Desmoid fibromatosis is a clonal process. Hum Pathol. 1996;27(9):939–943
  18. Bacac M, Migliavacca E, Stehle J-C, et al. A gene expression signature that distinguishes desmoid tumours from nodular fasciitis. J Pathol. 2006;208:543–553
  19. Taconis WK, Schutte HE. Van der Heul RO. Desmoplastic fibroma of bone: a report of 18 cases. Skelet Radiol. 1994;23:283–288
  20. Hoos A, Lewis JJ, Antonescu CR, et al. Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors. Cancer Res. 2001;61(April 1):3171–2175
  21. Fletcher JA, Naeem R, Xiao S, Corson JM. Chromosome aberrations in desmoid tumors. Cancer Genet Cytogenet. 1995;79(139):143
  22. Kouho H, Aoki T, Hisaoka M, Hashimoto H. Clinicopathological and interphase cytogenetic analysis of desmoid tumors. Histopathology. 1997;31:336–341
  23. Bridge JA, Swarts SJ, Buresh C, et al. Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. Am J Pathol. 1999;154:729–733
  24. Kopp P, Jaggi R, Tobler A, et al. Clonal X-inactivation analysis of human tumours using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue. Mol Cell Probes. 1997;11(3):217–228
  25. Muller E, Castagnaro M, Yandel D, Wolfe H, Alman BA. Molecular genetic and immunohistochemical analysis of the tumor suppressor genes Rb and P53 in palmar and aggressive fibromatosis. Diag Mol Pathol. 1996;5(3):194–200
  26. Smits R. Van der Houven van Oordt W, Luz A, et al. Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. Gastroenterology. 1998;114:275–283
  27. Robbins DH, Itzkowitz SH. The molecular and genetic basis of colon cancer. Med Clin North Am. 2002;86(6):1467–1495
  28. Brueckl WM, Preuss JM, Wein A, et al. Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients. Anticancer Res. 2001;21(5):3615–3620
  29. Gebert C, Hardes J, Kersting C, et al. Expression of beta-catenin and p53 are prognostic factors in deep aggressive fibromatosis. Histopathology. 2007;50(4):491–497
  30. Clark SK, Neale KF, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg. 1999;86(9):1185–1189
  31. Couture J, Mitri A, Lagace R, et al. A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet. 2000;57:205–212
  32. Gurbuz AK, Giardiello FM, Petersen GM. Desmoids tumours in familial adenomatous polyposis. Gut. 1994;35:377–381
  33. Latchford AR, Sturt NJH, Neale K, Rogers PA, Phillips R. A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg. 2006;93:1258–1264
  34. Speake D, Evans DG, Lalloo F, Scott NA, Hill J. Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations. Br J Surg. 2007;94(8):1009–1013
  35. Smith KJ, Johnson KA, Bryan TM, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA. 1993;90(7):2846–2850
  36. Lamlum H, Ilyas M, Rowan A, et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's ‘two-hit’ hypothesis. Nat Med. 1999;5(9):1071–1075
  37. Bertario L, Russo A, Sala P, et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer. 2001;95:102–107
  38. Gould KA, Dietrich WF, Borenstein N, Lander ES, Dove WF. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice. Genetics. 1996;144(4):1769–1776
  39. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo MM. Loss of APC heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated APC gene. Proc Natl Acad Sci USA. 1995;92(10):4482–4486
  40. Smits R, Kielman MF, Breukel C, et al. Apc1638T: a Mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev. 1999;13(10):1309–1321
  41. Su LK, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science. 1992;256(5057):668–670
  42. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, KikuchiAxin A. a negative regulator of the wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J. 1998;17(5):1371–1384
  43. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin–tcf complex in APC−/− colon carcinoma. Science. 1997;275:1784–1787
  44. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin–tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997;275(5307):1787–1790
  45. He TC, Sparks AB, Rago C, et al. Identification of C-MYC as a target of the APC pathway. Science. 1998;281(5382):1509–1512
  46. van de Wetering M, Sancho E, Verweij C, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002;111(2):241–250
  47. Saito T, Oda Y, Kawaguchi K-I, et al. Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction. Lab Invest. 2002;82(1):97–103
  48. Trent JM, Wiltshire R, Su LK, et al. The gene for the APC-binding protein beta-catenin (CTNNB1) maps to chromosome 3p22, a region frequently altered in human malignancies. Cytogenet Cell Genet. 1995;71(4):343–344
  49. Miyaki M, Konishi M, Kikuchi-Yanoshita R, et al. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res. 1993;53(21):5079–5082
  50. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatosis (desmoid tumor). Am J Pathol. 1997;151:329–334
  51. Miyoshi Y, Iwao K, Nawa G, Yoshikawa H, Ochi T, Nakamura Y. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res. 1998;10(11-12):591–594
  52. Tejpar S, Michils G, Denys H, et al. Analysis of Wnt/beta catenin signalling in desmoid tumors. Acta Gastroenterol Belg. 2005;68(1):5–9
  53. Brueckl WM, Ballhausen WG, Fortsch T, et al. Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma. Dis Colon Rectum. 2005;48(6):1275–1281
  54. Giarola M, Wells D, Mondini P, et al. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumors. Br J Cancer. 1998;78(5):582–587
  55. Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol. 1998;153(3):709–714
  56. Shitoh K, Konishi F, Iijima T, et al. A novel case of a sporadic desmoid tumour with mutation of the beta-catenin gene. J Clin Pathol. 1999;52:695–696
  57. Poon R, Smits R, Li C, et al. Cyclooxygenase-Two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene. 2001;20(4):451–460
  58. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene. 1999;18(47):6615–6620
  59. Tajima S, Hironaka M, Oshikawa K, et al. Intrathoracic sporadic desmoid tumor with the beta-catenin gene mutation in exon 3 and activated cyclin D1. Respiration. 2006;73(4):558–561
  60. Cheon SS, Cheah AY, Turley S, et al. Beta-catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA. 2002;99(10):6973–6978
  61. Dangel A, Meloni A, Lynch HT, Sandberg AA. Deletion (5q) in a desmoid tumor of patient with Gardner's syndrome. Cancer Genet Cytogenet. 1994;78(1):94–98
  62. Sturt NJH, Gallagher MC, Bassett P, et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut. 2004;53(12):1832–1836
  63. van der Luijt R, Meera Khan P, Vasen HFA, et al. germline mutations in the 3′ part of APC Exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum Genet. 1996;98(6):727–734
  64. Halberg RB, Katzung DS, Hoff PD, et al. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci USA. 2000;97(7):3461–3466
  65. Li CF, MacDonald JR, Wei RY, et al. Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse. BMC Genomics. 2007;8(92):
  66. Fong Y, Rosen PP, Brennan MF. Multifocal desmoids. Surgery. 1993;114:902–906

PII: S0748-7983(08)01709-5

doi: 10.1016/j.ejso.2008.07.003

European Journal of Surgical Oncology
Volume 35, Issue 1 , Pages 3-10 , January 2009

Article Tools

* Image Usage & Resolution